Received Mar 8, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | N/A | — | IM / RA |
Appropriately 4 days after receiving Capvaxive 0.5 Ml Syringe, subject/reporter experienced reactivation of HZ virus, presenting as Shingles. Early stage dermatomes detected across ribs, upper arm, and face (eye adjacent) on Thursday afternoon. By Friday, rash had begun to progress to mid-stage. Shingles confirmed by general practitioner & ophthalmologist; 1st dose valacyclovir course initiated Friday evening. Rash progression appears slow; however, progression noted.
None
Hashimoto?s hypothyroidism, obesity, asthma
Tirzepitide, synthroid, levocertrizine, hydrochlorithiazide, progesterone, estrogen, ibuprofen
Doxycycline, Advair